Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
R&D Expenses Over TimeStable
Percentile Rank18
3Y CAGR-3.7%
5Y CAGR-0.5%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-3.7%/yr
vs -0.2%/yr prior
5Y CAGR
-0.5%/yr
Recent deceleration
Acceleration
-3.5pp
Decelerating
Percentile
P18
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
4 yr
Consecutive declineStable
PeriodValueYoY Change
2025$186.18M-2.4%
2024$190.71M-2.1%
2023$194.75M-6.7%
2022$208.66M-0.4%
2021$209.56M+10.0%
2020$190.59M-5.8%
2019$202.29M-3.9%
2018$210.45M+9.6%
2017$191.94M-6.3%
2016$204.75M-